Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFBP4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $66,016
Award facts
- Contract value 100% obligated
- $66,016.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $66,016 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of BOTOX 200 Unit Vials. The award, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, carries no set-aside designation, indicating that DMS Pharmaceutical Group competed successfully in unrestricted federal procurement. The order will be fulfilled at the company's Park Ridge facility and represents a discrete purchase under the company's broader relationship with the federal pharmaceutical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded on November 13, 2025, with a $499.999 billion ceiling value extending through December 31, 2036. The PPV-G GEN V represents a $30.3 billion federal acquisition strategy through which the DLA establishes multiple regional prime vendor contractors to supply pharmaceuticals, biologics, and medical consumables to Department of Defense healthcare facilities worldwide. This delivery order for BOTOX demonstrates DMS Pharmaceutical Group's capability to fulfill specialized pharmaceutical requirements within the broader military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FFBP4?
SPE2DR26FFBP4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FFBP4 worth?
The government has obligated $66,016 on SPE2DR26FFBP4.
Is contract SPE2DR26FFBP4 an order under another contract?
Yes. SPE2DR26FFBP4 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBP4 competed?
The extent of competition for SPE2DR26FFBP4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award